MedTrace Logo

Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green.

NCT00376857 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2006-09-15

No results posted yet for this study

Summary

It was the aim of the present study to prospectively compare the functional and morphological outcome of idiopathic epiretinal membrane surgery with and without the assistance of Indocyanine green (ICG). The main outcome measure was improvement of best-corrected visual acuity (BCVA). This was treated as an open question and we had no hypothesis which of the two therapies was superior.

Conditions

  • Idiopathic Epiretinal Membrane, Cataract

Interventions

DRUG

Surgery with and without the aid of Indocyanine Green (ICG)

Sponsors & Collaborators

  • University of Regensburg

    lead OTHER

Principal Investigators

  • Jost Hillenkamp, MD · Dept. of Ophthalmology, University of Regensburg

  • Parykshit Saikia, MD · Dept. of Ophthalmology, University of Regensburg

  • Helmut G Sachs, MD · Dept. of Ophthalmology, University of Regensburg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00376857 on ClinicalTrials.gov